Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target trial emulation study

ObjectivesTo compare the risk of incident uveitis among patients with axial spondyloarthritis initiating treatment with Janus kinase inhibitors (JAKi) versus tumor necrosis factor inhibitors (TNFi).MethodsWe conducted an emulated target trial using real-world electronic health records from the TriNe...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Wei-Hsuan Bai, Pei-Lun Liao, Yi-Chiao Bai, James Cheng-Chung Wei
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-10-01
Serija:	Frontiers in Immunology
Teme:	janus kinase inhibitors tumor necrosis factor inhibitors uveitis autoimmune disease TriNetX cohort study
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1673970/full
Oznake:	Označite Brez oznak, prvi označite!